Back
AbbVie Vs. Merck & Industry Stock Comparison
Sell
40
ABBV
AbbVie
Last Price:
181.14
Seasonality Move:
6.07%
Sell
33
MRK
Merck &
Last Price:
101.60
Seasonality Move:
2.47%
Sell
40
AbbVie (ABBV)
is a Sell
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $177.06. The Score for ABBV is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ABBV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Merck & (MRK)
is a Sell
Is Merck & a Buy, Sell or Hold?
- The current Merck & [MRK] share price is $101.16. The Score for MRK is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- MRK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABBV Stock Price Chart
MRK Stock Price Chart
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.88 | Sell |
Relative Strength Index (14 RSI): | 43.25 | Sell |
Chaikin Money Flow: | -10091734 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (171.12 - 198.68) | Sell |
Bollinger Bands (100): | (176.92 - 198.56) | Sell |
MRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.29 | Sell |
Relative Strength Index (14 RSI): | 47.35 | Sell |
Chaikin Money Flow: | 16531815 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (98.23 - 104.29) | Sell |
Bollinger Bands (100): | (104.41 - 121.45) | Sell |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 170.12 | Buy |
20-day SMA: | 183.93 | Sell |
50-day SMA: | 189.22 | Sell |
200-day SMA: | 178.81 | Sell |
8-day EMA: | 173.96 | Buy |
20-day EMA: | 179.62 | Sell |
50-day EMA: | 185.52 | Sell |
200-day EMA: | 178.56 | Sell |
MRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 98.18 | Buy |
20-day SMA: | 100.22 | Buy |
50-day SMA: | 106.93 | Sell |
200-day SMA: | 120.29 | Sell |
8-day EMA: | 99.18 | Buy |
20-day EMA: | 100.68 | Buy |
50-day EMA: | 105.6 | Sell |
200-day EMA: | 114.52 | Sell |
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.
Merck & Earnings Growth & MRK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.98 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.36 per share, and an increase next year of $1.75 per share.
AbbVie Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merck & Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |